EU contract didn’t leave enough time to fix hiccups-AstraZeneca CEO By Reuters

BERLIN (Reuters) – AstraZeneca’s CEO on Tuesday rejected accusations by the European Union that the pharma company had provided insufficient clarification at a meeting this week on its decision to slow down supplies of COVID-19 vaccines to the bloc.

“We are basically two months behind where we wanted to be (in Europe),” Pascal Soriot told German daily Die Welt in an interview to be published on Wednesday.

“And the issue here is we’ve had also teething issues like this in the UK supply chain,” he added. “As for Europe, we are three months behind in fixing those glitches.”